Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
Titel:
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
Auteur:
Faivre-Finn, Corinne Snee, Michael Ashcroft, Linda Appel, Wiebke Barlesi, Fabrice Bhatnagar, Adityanarayan Bezjak, Andrea Cardenal, Felipe Fournel, Pierre Harden, Susan Le Pechoux, Cecile McMenemin, Rhona Mohammed, Nazia O'Brien, Mary Pantarotto, Jason Surmont, Veerle Van Meerbeeck, Jan P Woll, Penella J Lorigan, Paul Blackhall, Fiona
Verschenen in:
Lancet oncology
Paginering:
Jaargang 18 (2017) nr. 8 pagina's 1116-1125
Jaar:
2017
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC-BY 4.0 license